According to a new study, psoriasis patients, with and without psoriatic arthritis (PsA), self-report using analgesics more than those without the disease. This may be due to increased joint pain.
Ustekinumab less effective for psoriasis in lower extremities, according to study
A new study has shown that clinical response in psoriasis patients treated with ustekinumab tends to vary by anatomical region, with the lower extremities seeing the least response.
Study shows early response to biologics linked to stable long-term efficacy in psoriasis
Findings from a new study has shown that early response to ixekizumab and ustekinumab is associated with maintaining stable long-term skin clearance in patients with moderate-to-severe psoriasis.
Self-help interventions help reduce shame and improve QOL in psoriasis patients, study shows
According to a new study, some psoriasis patients may experience a reduction in shame and improvement in quality of life (QOL) after exposure to self-help interventions.
Psoriasis patients experience vaccine hesitancy and treatment disruptions during pandemic
A new study evaluates vaccine hesitancy and medication changes in psoriasis patients during the Covid-19 pandemic.
New study shows Tapinarof cream reduces severity of plaque psoriasis
Tapinarof 1% cream was superior to vehicle control in reducing the severity of plaque psoriasis over a 12 week period, according to a new study.
New study links key protein to inflammation in psoriasis patients
Researchers have linked a key protein called TWEAK to inflammation in psoriasis patients.
Risankizumab worsened symptoms in patients with severe asthma, new study finds
A new study tested risankizumab, approved for the treatment of psoriasis, in patients with severe asthma and found it worsened their asthma symptoms.
Researchers gather real world treatment data on psoriatic arthritis patients
Researchers have surveyed 137 respondents from a psoriatic arthritis (PsA) registry for phenotypic features and characteristics, initial and current therapies, and medication preference.
Hepatitis C linked to increased risk for chronic inflammatory skin diseases, study shows
According to a new study, hepatitis C virus (HCV) infection is linked to an increased risk for chronic inflammatory skin diseases (CISDs). The study showed a decreased risk for CISD when treated with interferon-based antiviral therapy.
HealthMinute.TV 